Overview

Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The implications of sleep as it relates to the physiology and pathogenesis of a number of diseases has until recently been ignored. With the evolution of sleep laboratories, there is an emerging recognition of the relationship between sleep and various gastrointestinal diseases- in particular gastroesophageal reflux disease (GERD).( 1-5) It seems intuitive that waking/daytime activities or events may affect sleep and that any consequent sleep dysfunction may reciprocally further affect daytime function
Phase:
N/A
Details
Lead Sponsor:
David A. Johnson, MD
Collaborator:
AstraZeneca
Treatments:
Esomeprazole